Stage IV Uterine Corpus Cancer AJCC v7

11 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Stage IV Uterine Corpus Cancer AJCC v7

Record	Firm	Date
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer (NCT03120624)	Mayo Clinic	2017-09-15
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer (NCT02684227)	M.D. Anderson Cancer Center	2016-08-24
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer (NCT03902379)	Rutgers, The State University of New Jersey	2016-07-27
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian (NCT02208375)	M.D. Anderson Cancer Center	2014-11-11
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer (NCT01970722)	City of Hope Medical Center	2014-05-19
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer (NCT02065687)	Gynecologic Oncology Group	2014-03-17
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (NCT01440998)	National Cancer Institute (NCI)	2011-09-20
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery (NCT00410553)	National Cancer Institute (NCI)	2006-11-14
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer (NCT00006903)	Gynecologic Oncology Group	2004-08-30
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00006089)	National Cancer Institute (NCI)	2000-09-18

Track Stage IV Uterine Corpus Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.